Navigation

Vicodin HP

  • Generic Name: hydrocodone bitartrate and acetaminophen tablets
  • Brand Name: Vicodin HP

Vicodin HP(Hydrocodone Bitartrate and Acetaminophen Tablets) side effects drug center

Vicodin HP Side Effects Center

What Is Vicodin HS?

Vicodin HP (hydrocodone bitrate and acetaminophen tablets) is a combination of a narcotic pain reliever and an analgesic pain reliever used to relieve moderate to severe pain. Vicodin HP is available in generic form.

What Are Side Effects of Vicodin HS?

Common side effects of Vicodin HP include:

  • nausea, vomiting, constipation, upset stomach, lightheadedness, dizziness, drowsiness, anxiety, headache, mood changes, blurred vision, ringing in your ears, or dry mouth.

    Dosage for Vicodin HS

    The usual adult dosage of Vicodin HP is one tablet (hydrocodone bitartrate and acetaminophen, 10 mg/660 mg) every four to six hours as needed for pain. The total daily dosage should not exceed 6 tablets.

    What Drugs, Substances, or Supplements Interact with Vicodin HS?

    Vicodin HP may interact with antidepressants, MAO inhibitors, atropine, benztropine, dimenhydrinate, glycopyrrolate, mepenzolate, methscopolamine, scopolamine, bladder or urinary medications, bronchodilators, or irritable bowel medications. Tell your doctor all medications you are taking.

    Vicodin HS During Pregnancy or Breastfeeding

    During pregnancy, Vicodin HP should be used only when prescribed. Using it near the expected delivery date is not recommended because of the potential for harm to the fetus. Babies born to mothers who have used this medication may have withdrawal symptoms such as irritability, abnormal/persistent crying, vomiting, or diarrhea. If you notice any of these symptoms in your newborn, tell the doctor. This medication passes into breast milk and may rarely have undesirable effects on a nursing infant. Tell the doctor if your baby develops unusual sleepiness, difficulty feeding, or trouble breathing. Consult your doctor before breastfeeding. Vicodin HP contains hydrocodone, which can be addicting. Withdrawal reactions (e.g., restlessness, watering eyes, runny nose, nausea, sweating, muscle aches) may occur if you suddenly stop using this medication.

    Additional Information

    Our Vicodin HP (hydrocodone bitrate and acetaminophen tablets) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

Vicodin HP Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Opioid medicine can slow or stop your breathing, and death may occur. A person caring for you should give naloxone and/or seek emergency medical attention if you have slow breathing with long pauses, blue colored lips, or if you are hard to wake up.

In rare cases, acetaminophen may cause a severe skin reaction that can be fatal. This could occur even if you have taken acetaminophen in the past and had no reaction. Stop taking this medicine and call your doctor right away if you have skin redness or a rash that spreads and causes blistering and peeling.

Call your doctor at once if you have:

  • noisy breathing, sighing, shallow breathing, breathing that stops;
  • a light-headed feeling, like you might pass out;
  • liver problems--nausea, upper stomach pain, tiredness, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • low cortisol levels-- nausea, vomiting, loss of appetite, dizziness, worsening tiredness or weakness; o
  • high levels of serotonin in the body--agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, diarrhea.

Serious breathing problems may be more likely in older adults and in those who are debilitated or have wasting syndrome or chronic breathing disorders.

Common side effects include:

  • dizziness, drowsiness, feeling tired;
  • nausea, vomiting, stomach pain;
  • constipation; or
  • headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Vicodin HP (Hydrocodone Bitartrate and Acetaminophen Tablets)

Vicodin HP Professional Information

SIDE EFFECTS

The most frequently reported adverse reactions are lightheadedness, dizziness, sedation, nausea and vomiting. These effects seem to be more prominent in ambulatory than in nonambulatory patients, and some of these adverse reactions may be alleviated if the patient lies down.

Other adverse reactions include

Central Nervous System

Drowsiness, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, dysphoria, psychic dependence, mood changes.

Gastrointestinal System

Prolonged administration of VICODIN HP (hydrocodone bitrate and acetaminophen tablets) Tablets may produce constipation.

Genitourinary System

Ureteral spasm, spasm of vesical sphincters and urinary retention have been reported with opiates.

Respiratory Depression

Hydrocodone bitartrate may produce dose-related respiratory depression by acting directly on the brain stem respiratory centers (see OVERDOSAGE).

Special Senses

Cases of hearing impairment or permanent loss have been reported predominantly in patients with chronic overdose.

Dermatological

Skin rash, pruritus.

The following adverse drug events may be borne in mind as potential effects of acetaminophen: allergic reactions, rash, thrombocytopenia, agranulocytosis.

Potential effects of high dosage are listed in the OVERDOSAGE section.

Drug Abuse And Dependence

Misuse, Abuse, and Diversion of Opioids

VICODIN HP (hydrocodone bitrate and acetaminophen tablets) contains hydrocodone, an opioid agonist, and is a Schedule III controlled substance. VICODIN HP (hydrocodone bitrate and acetaminophen tablets) , and other opioids, used in analgesia can be abused and are subject to criminal diversion.

Addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving. Drug addiction is a treatable disease utilizing a multidisciplinary approach, but relapse is common.

“Drug seeking” behavior is very common in addicts and drug abusers. Drug-seeking tactics include emergency calls or visits near the end of office hours, refusal to undergo appropriate examination, testing or referral, repeated “loss” of prescriptions, tampering with prescriptions and reluctance to provide prior medical records or contact information for other treating physician(s). “Doctor shopping” to obtain additional prescriptions is common among drug abusers and people suffering from untreated addiction.

Abuse and addiction are separate and distinct from physical dependence and tolerance. Physical dependence usually assumes clinically significant dimensions only after several weeks of continued opioid use, although a mild degree of physical dependence may develop after a few days of opioid therapy. Tolerance, in which increasingly large doses are required in order to produce the same degree of analgesia, is manifested initially by a shortened duration of analgesic effect, and subsequently by decreases in the intensity of analgesia. The rate of development of tolerance varies among patients. Physicians should be aware that abuse of opioids can occur in the absence of true addiction and is characterized by misuse for non-medical purposes, often in combination with other psychoactive substances. VICODIN HP (hydrocodone bitrate and acetaminophen tablets) , like other opioids, may be diverted for non-medical use. Record-keeping of prescribing information, including quantity, frequency, and renewal requests is strongly advised.

Proper assessment of the patient, proper prescribing practices, periodic re-evaluation of therapy, and proper dispensing and storage are appropriate measures that help to limit abuse of opioid drugs.

Read the entire FDA prescribing information for Vicodin HP (Hydrocodone Bitartrate and Acetaminophen Tablets)

© Vicodin HP Patient Information is supplied by Cerner Multum, Inc. and Vicodin HP Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.